Coverage for all adult vaccines (regulation related to Public Health Service Act, Sec 2713); Appropriations related to CDC report on arbovirus threat; Appropriations related to funding the State Stockpile Grant program; Issues related to Strategic National Stockpile procurement regarding new emerging infection diseases and in relation to the Preparedness Act (PAHPA) reauthorization; Issues related to the FDA's Priority Review Voucher; Issues related to reauthorization of the publican health emergency medical countermeasures enterprise; Enhancing immunization access for military dependents
2025 · 2nd Quarter (Apr 1 - June 30)
VALNEVA USA, INC.
Filed by VALNEVA USA, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- Not reported
- Expenses
- $110,000.00
- Registrant
- VALNEVA USA, INC.
- Client
- VALNEVA USA, INC.
- Filing UUID
- b7265613-44a7-4a1b-8e16-a5b65ff5d602
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.